CI Investments Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,881
Closed -$339K 1328
2025
Q1
$339K Sell
4,881
-191,554
-98% -$15.8M ﹤0.01% 604
2024
Q4
$16.9M Buy
196,435
+182,973
+1,359% +$19.8M 0.06% 190
2024
Q3
$1.6M Sell
13,462
-149,785
-92% -$20M 0.01% 366
2024
Q2
$23.3M Sell
163,247
-1,758
-1% -$233K 0.09% 155
2024
Q1
$21.2M Sell
165,005
-51,868
-24% -$6.17M 0.08% 165
2023
Q4
$22.4M Sell
216,873
-54,984
-20% -$5.44M 0.12% 158
2023
Q3
$24.7M Buy
271,857
+27,403
+11% +$2.41M 0.14% 142
2023
Q2
$19.8M Buy
+244,454
New +$20M 0.1% 169
2021
Q1
Sell
-1,600
Closed -$56K 1042
2020
Q4
$56K Sell
1,600
-4,400
-73% -$152K ﹤0.01% 825
2020
Q3
$208K Sell
6,000
-800
-12% -$26.7K ﹤0.01% 573
2020
Q2
$223K Sell
6,800
-600
-8% -$19.1K ﹤0.01% 523
2020
Q1
$223K Sell
7,400
-5,000
-40% -$149K ﹤0.01% 482
2019
Q4
$359K Sell
12,400
-11,400
-48% -$316K ﹤0.01% 537
2019
Q3
$615K Buy
23,800
+8,800
+59% +$223K ﹤0.01% 411
2019
Q2
$386K Buy
+15,000
New +$371K ﹤0.01% 290

Other funds holding NVO

CI Investments Inc's NVO Position: Q2 2025 in Review

CI Investments Inc sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 4,881 shares — an estimated $339K sold.

CI Investments Inc first reported a position in NVO in Q2 2019 and held it in 15 quarters. The position peaked at $24.7M in Q3 2023. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • CI Investments Inc reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 4,881 Novo Nordisk shares in Q2 2025, an estimated $339K.
  • CI Investments Inc first reported a position in Novo Nordisk in Q2 2019 and held it in 15 quarters.
  • CI Investments Inc's Novo Nordisk position peaked at $24.7M in Q3 2023.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.